-
公开(公告)号:US20070287699A1
公开(公告)日:2007-12-13
申请号:US11742461
申请日:2007-04-30
申请人: Dange Kumar , Roopa Rai , Wendy Young , Huiyong Hu , Jennifer Riggs , Tony Ton , Michael Green , Barry Hart , Kenneth Brameld , Jeffrey Dener
发明人: Dange Kumar , Roopa Rai , Wendy Young , Huiyong Hu , Jennifer Riggs , Tony Ton , Michael Green , Barry Hart , Kenneth Brameld , Jeffrey Dener
IPC分类号: A61K31/4709 , A61K31/496 , A61K31/5355 , A61K31/541 , A61K31/551 , A61P31/14 , C07D215/233 , C07D243/08 , C07D279/12 , C07D401/04 , C07D413/04 , C07D455/02 , C07D471/04
CPC分类号: C07D413/14 , C07D413/04
摘要: Compounds are provided having utility for the treatment of viral infections, particularly HCV.
摘要翻译: 提供了可用于治疗病毒感染,特别是HCV的化合物。
-
公开(公告)号:US20070032522A1
公开(公告)日:2007-02-08
申请号:US11478371
申请日:2006-06-28
申请人: Dange Kumar , Roopa Rai
发明人: Dange Kumar , Roopa Rai
IPC分类号: A61K31/4704
CPC分类号: C07D215/56 , C07D215/38 , C07D401/06
摘要: The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
摘要翻译: 本发明涉及作为抗病毒剂的化合物。 具体地说,本发明的化合物抑制HCV的复制,因此可用于治疗丙型肝炎感染。 本发明还涉及包含这些化合物的药物组合物及其制备方法。
-